Vivos Therapeutics acquires assets
- Entered into a Mutual Stock Purchase and Asset Exchange Agreement with SOD Sciences.
- Issued 12,000 shares of Series C Preferred Stock valued at $12M.
- Acquired 50% co-ownership interest in the ReBalU Protocol.
VVOS
Vivos Therapeutics, Inc. SEC filings
Every EDGAR filing for Vivos Therapeutics, Inc. (VVOS), newest first, with AI summaries and stories.
- Ticker
- VVOS
- CIK
- 1716166
- Sector
- Medical devices
- Latest filing
- 4d
Next: earnings expected ~Nov 16 · 10-Q expected ~Nov 16 (deadline Nov 16)
Filings
8-KVivos Therapeutics, Inc.VVOSLIVE 8-KVivos Therapeutics, Inc.VVOSLIVE 4Vivos Therapeutics, Inc.VVOSLIVE 2 insider filings
Leonard J Sokolow, insider filing for VVOS
Show all 2
- 4Insider filing for VVOS
- 4Insider filing for VVOS
Leonard J Sokolow, reporting
4Vivos Therapeutics, Inc.VVOSLIVE Ronald Kirk Huntsman, insider filing for VVOS
Ronald Kirk Huntsman, reporting
8-K/AVivos Therapeutics, Inc.VVOSLIVE SCHEDULE 13G/AVivos Therapeutics, Inc.VVOSLIVE Ownership stake disclosure by Streeterville Capital LLC (amended)
Streeterville Capital LLC, filed by
4Vivos Therapeutics, Inc.VVOSLIVE Bradford K. Amman, insider filing for VVOS
Bradford K. Amman, reporting
8-KVivos Therapeutics, Inc.VVOSLIVE 10-QVivos Therapeutics, Inc.VVOSLIVE SCHEDULE 13G/AVivos Therapeutics, Inc.VVOSLIVE Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)
ARMISTICE CAPITAL, LLC, filed by
8-KVivos Therapeutics, Inc.VVOSLIVE SCHEDULE 13GVivos Therapeutics, Inc.VVOSLIVE Ownership stake disclosure by Streeterville Capital LLC
Streeterville Capital LLC, filed by
8-KVivos Therapeutics, Inc.VVOSLIVE SCHEDULE 13DVivos Therapeutics, Inc.VVOSLIVE Ownership stake disclosure by V-Co Investors 4 LLC
V-Co Investors 4 LLC, filed by
4Vivos Therapeutics, Inc.VVOSLIVE 2 insider filings
Michael C Skaff, insider filing for VVOS
Show all 2
- 4Insider filing for VVOS
- 3New insider at VVOS
Michael C Skaff, reporting
8-KVivos Therapeutics, Inc.VVOSLIVE 8-KVivos Therapeutics, Inc.VVOSLIVE 8-KVivos Therapeutics, Inc.VVOSLIVE 8-KVivos Therapeutics, Inc.VVOSLIVE 10-QVivos Therapeutics, Inc.VVOSLIVE NT 10-QVivos Therapeutics, Inc.VVOSLIVE SCHEDULE 13GVivos Therapeutics, Inc.VVOSLIVE Ownership stake disclosure by ARMISTICE CAPITAL, LLC
ARMISTICE CAPITAL, LLC, filed by
EFFECTVivos Therapeutics, Inc.VVOSLIVE 424B3Vivos Therapeutics, Inc.VVOSLIVE 8-KVivos Therapeutics, Inc.VVOSLIVE 8-KVivos Therapeutics, Inc.VVOSLIVE 10-KVivos Therapeutics, Inc.VVOSLIVE 3Vivos Therapeutics, Inc.VVOSLIVE V-Co Investors 3 LLC, new insider at VVOS
V-Co Investors 3 LLC, reporting
8-KVivos Therapeutics, Inc.VVOSLIVE 4Vivos Therapeutics, Inc.VVOSLIVE Michael C Skaff, insider filing for VVOS
Michael C Skaff, reporting · V-Co Investors 3 LLC, reporting
SCHEDULE 13DVivos Therapeutics, Inc.VVOSLIVE Ownership stake disclosure by V-Co Investors 3 LLC
V-Co Investors 3 LLC, filed by
NT 10-KVivos Therapeutics, Inc.VVOSLIVE 3Vivos Therapeutics, Inc.VVOSLIVE Gregg C Johnson, new insider at VVOS
Gregg C Johnson, reporting
8-KVivos Therapeutics, Inc.VVOSLIVE 8-KVivos Therapeutics, Inc.VVOSLIVE 8-KVivos Therapeutics, Inc.VVOSLIVE 424B3Vivos Therapeutics, Inc.VVOSLIVE EFFECTVivos Therapeutics, Inc.VVOSLIVE POS AMVivos Therapeutics, Inc.VVOSLIVE 8-KVivos Therapeutics, Inc.VVOSLIVE 10-QVivos Therapeutics, Inc.VVOSLIVE Vivos Therapeutics, Inc. filed 10-Q
- Form Type: 10-Q
- Filing Date: 2025-11-19
8-KVivos Therapeutics, Inc.VVOSLIVE Vivos Therapeutics, Inc. reported: Results of Operations and Financial Condition.
- Item 2.02. Results of Operations and Financial Condition.
- Item 9.01. Financial Statements and Exhibits.
NT 10-QVivos Therapeutics, Inc.VVOSLIVE 8-KVivos Therapeutics, Inc.LIVE